Terms: = Ovarian cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
957 results:
1. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and emt.
You S; Han X; Xu Y; Sui L; Song K; Yao Q
Cancer Med; 2024 May; 13(10):e7217. PubMed ID: 38752472
[TBL] [Abstract] [Full Text] [Related]
2. IL-6 regulates epithelial ovarian cancer emt, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
Guo QY; Song JN; Chen YM; Yuan HN; Xue WS; Sun Y; Niu XL; Wang Y; Chen X
Med Oncol; 2024 May; 41(6):155. PubMed ID: 38744773
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract] [Full Text] [Related]
4. Tumour-derived exosome SNHG17 induced by oestrogen contributes to ovarian cancer progression via the CCL13-CCR2-M2 macrophage axis.
Liang H; Geng S; Wang Y; Fang Q; Xin Y; Li Y
J Cell Mol Med; 2024 May; 28(9):e18315. PubMed ID: 38680032
[TBL] [Abstract] [Full Text] [Related]
5. ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC.
Böpple K; Oren Y; Henry WS; Dong M; Weller S; Thiel J; Kleih M; Gaißler A; Zipperer D; Kopp HG; Aylon Y; Oren M; Essmann F; Liang C; Aulitzky WE
Cell Death Dis; 2024 Apr; 15(4):290. PubMed ID: 38658567
[TBL] [Abstract] [Full Text] [Related]
6. An LRPPRC-HAPSTR1-PSMD14 interaction regulates tumor progression in ovarian cancer.
Li D; Wang M
Aging (Albany NY); 2024 Apr; 16(8):6773-6795. PubMed ID: 38643468
[TBL] [Abstract] [Full Text] [Related]
7. A Stem-like Patient-Derived ovarian cancer Model of Platinum Resistance Reveals Dissociation of Stemness and Resistance.
Suzuki T; Conant A; Jung Y; Bax R; Antonissen A; Chen W; Yu G; Ioffe YJ; Wang C; Unternaehrer JJ
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612653
[TBL] [Abstract] [Full Text] [Related]
8. Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing.
Kong D; Wu Y; Liu Q; Huang C; Wang T; Huang Z; Gao Y; Li Y; Guo H
Eur J Med Res; 2024 Apr; 29(1):231. PubMed ID: 38609993
[TBL] [Abstract] [Full Text] [Related]
9. FSH induces emt in ovarian cancer via ALKBH5-regulated Snail m6A demethylation.
Xu X; Zhuang X; Yu H; Li P; Li X; Lin H; Teoh JP; Chen Y; Yang Y; Cheng Y; Chen W; Fu X
Theranostics; 2024; 14(5):2151-2166. PubMed ID: 38505602
[No Abstract] [Full Text] [Related]
10. cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
[TBL] [Abstract] [Full Text] [Related]
11. Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.
Li J; Sun Y; Zhi X; Sun Y; Abudousalamu Z; Lin Q; Li B; Yao L; Chen M
J Ovarian Res; 2024 Mar; 17(1):61. PubMed ID: 38486335
[TBL] [Abstract] [Full Text] [Related]
12. A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.
Sun Y; Zhang K; Wang T; Zhao S; Gao C; Xue F; Wang Y
Sci Rep; 2024 Mar; 14(1):6134. PubMed ID: 38480789
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning developed a CD8
Chen R; Zheng Y; Fei C; Ye J; Fei H
Sci Rep; 2024 Mar; 14(1):5794. PubMed ID: 38461331
[TBL] [Abstract] [Full Text] [Related]
14. Expression of HIF-1α, Ki67, SMA and E-cadherin in endometriosis, endometrial and ovarian carcinoma.
Markov D; Poryazova E; Raycheva R; Markov G
Folia Med (Plovdiv); 2024 Feb; 66(1):97-103. PubMed ID: 38426471
[TBL] [Abstract] [Full Text] [Related]
15. Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an ovarian Tumor.
Chen X; Yan Y; Liu Y; Yi Q; Xu Z
J Nat Prod; 2024 Apr; 87(4):837-848. PubMed ID: 38417401
[TBL] [Abstract] [Full Text] [Related]
16. The miR-1290/OGN axis in ovarian cancer-associated fibroblasts modulates cancer cell proliferation and invasion.
Jiang B; Xiao S; Zhang S; Xiao F
J Ovarian Res; 2024 Feb; 17(1):52. PubMed ID: 38402185
[TBL] [Abstract] [Full Text] [Related]
17. Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway.
Wang H; Xu YH; Guo Y
J Ovarian Res; 2024 Feb; 17(1):50. PubMed ID: 38395907
[TBL] [Abstract] [Full Text] [Related]
18. TMCO1 regulates cell proliferation, metastasis and emt signaling through CALR, promoting ovarian cancer progression and cisplatin resistance.
Sun G; Gong S; Lan S; He Y; Sun Y; Zhang Z
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):99-109. PubMed ID: 38372107
[TBL] [Abstract] [Full Text] [Related]
19. Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer.
Xu T; Verhagen MP; Teeuwssen M; Sun W; Joosten R; Sacchetti A; Ewing-Graham PC; Jansen MPHM; Boere IA; Bryce NS; Zeng J; Treutlein HR; Hook J; Hardeman EC; Gunning PW; Fodde R
Cell Death Differ; 2024 Mar; 31(3):360-377. PubMed ID: 38365970
[TBL] [Abstract] [Full Text] [Related]
20. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract] [Full Text] [Related]
[Next]
